信立泰(002294.SZ):2021年度淨利預增657.00%-883.23%
格隆匯1月17日丨信立泰(002294.SZ)披露2021年度業績預吿,預計2021年度實現歸屬於上市公司股東的淨利潤4.61億元-5.98億元,同比增長657.00%-883.23%;預計2021年度實現歸屬於上市公司股東的扣除非經常性損益後的淨利潤2.46億元-3.19億元,同比增長6267.90%-8170.95%。業績預增原因系:
1、公司創新產品信立坦的目標市場——高血壓和慢性腎臟疾病領域,既有未被滿足的臨牀需求,又有由於集採後傳統競爭對手留下的市場空間,且新上市的創新產品有限,競爭格局及市場前景均好;公司根據信立坦的特點並結合最新醫學發展趨勢,制定信立坦產品生命週期管理規劃,加大渠道建設及推廣力度,實現較好的增長;在國家引導、支持創新的政策下,積極參與該產品的醫保談判,新一輪的談判價格為4.3元(240mg/片),為進入更廣闊的基層市場奠定基礎。另外,在帶量採購政策下,泰嘉作為一款極具臨牀價值的優秀產品,以優質優價積極推廣,達成銷售目標;同時,信立欣等多個產品的中標,為公司帶來一定的利潤貢獻和穩定的現金流。
2、2021年度,公司根據會計準則對資產進行清理,合計計提資產減值準備約1.47億元。其中,基於對未來桓晨的盈利等相關情況的預期,對併購桓晨形成的資產組的可回收價值進行減值測試,結果表明相關資產組中的無形資產存在減值跡象,基於謹慎性原則,2021年第四季度,公司就該桓晨資產組無形資產計提減值準備1.2億元,預計對淨利潤影響約1億元。
3、2021年度,預計公司非經常性損益對歸屬於上市公司股東的淨利潤影響金額約2.15億元-2.8億元,主要系公司全資子公司諾泰國際有限公司以4500萬美元向ROSY METRO LIMITED轉讓其持有的M.A. MED ALLIANCE SA 5.691萬股股權,預計對淨利潤影響約1.59億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.